Varanakis Ann 4/A
4/A · LifeStance Health Group, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4/AAmended
Varanakis Ann
Chief People Officer
Transactions
- Tax Payment
Common Stock
2025-03-06$7.88/sh−6,455$50,865→ 332,694 total - Award
Common Stock
2025-03-06+76,142→ 339,149 total - Award
Common Stock
2025-03-07+27,740→ 360,434 total - Award
Common Stock
2025-03-07+32,052→ 385,036 total - Tax Payment
Common Stock
2025-03-07$7.59/sh−7,450$56,546→ 352,984 total - Tax Payment
Common Stock
2025-03-07$7.59/sh−8,606$65,320→ 376,430 total
Footnotes (6)
- [F1]Includes 76,142 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
- [F3]Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
- [F4]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
- [F5]Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.
- [F6]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.